Compugen Ltd. announced yesterday the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. I will follow this story to see if it has any relevance to patients like you or me. Sorry, but I start to get frustrated with “test tube” type research which may ultimately not help us–at least not in our lifetimes.
Feel good and keep smiling! I will keep you updated- Pat